Mechanisms of Disease: Unraveling the Small Molecule Pipeline for IBD

Improvements in Targeted IBD Management: Innovative Biologics and Small MoleculesПодробнее

Understanding the mechanisms of action of new agents: Implications for efficacy and safetyПодробнее

IBD: Identified uncertainties in optimising biologic & small molecule medicines –the latest evidenceПодробнее

IBD Clinical Update: New and Emerging Targeted TherapiesПодробнее

Deciphering the Signaling Mechanisms Involved in the Future Therapeutic Management of IBDПодробнее

JAK Inhibitors and Inflammatory Bowel DiseaseПодробнее

Tiny but Mighty: The New Small Molecules in IBD TreatmentПодробнее

Mechanisms of Disease: Biologic Pipeline for IBDПодробнее

Navigating Mechanisms of UC TherapiesПодробнее

Antibiotics and Risk of New Onset Inflammatory Bowel Disease: A Meta-AnalysisПодробнее

New and Emerging Treatments for Inflammatory Bowel DiseaseПодробнее

How will future therapeutic pathways change for ulcerative colitis and Crohn's disease?Подробнее

Emerging Therapies in IBD - Dr. HanauerПодробнее

Current and Evolving Therapeutic Landscape of IBDПодробнее

How Does IBD Happen? Understanding the Immune SystemПодробнее

New Therapies that Target the JAK-STAT Pathway and other Small MoleculesПодробнее

Understanding Treatment Options in IBDПодробнее

Inflammatory Bowel Disease (IBD) | Clinical MedicineПодробнее

Therapeutic Drug Monitoring in IBD: When, How, and for Which Drugs?Подробнее